Related Experiment Video
Updated: Jun 28, 2026

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System
Published on: May 5, 2018
[Genetic and congenital heart defects]
1Servicio de Cardiología Pediátrica, Instituto Nacional de Cardiología "Ignacio Chávez", INCICH, Juan Badiano Número 1, Col. Sección XVI, Tlalpan 14080, México, DF. juanecalderon@yahoo.com.mx
Genetic mutations in TBX5 cause Holt-Oram syndrome, a condition involving congenital heart disease and limb defects. Research is advancing our understanding of its genetic basis and potential therapeutic improvements.
Area of Science:
- Genetics
- Developmental Biology
- Cardiology
Context:
- Congenital heart disease (CHD) etiology is increasingly understood through its genetic underpinnings.
- Holt-Oram syndrome is an autosomal-dominant disorder linked to specific genetic mutations.
- This condition presents with both cardiac anomalies and upper limb malformations.
Purpose:
- To review recent advancements in the study of Holt-Oram syndrome.
- To explore the genetic basis of Holt-Oram syndrome, focusing on TBX5 mutations.
- To discuss the clinical implications and potential therapeutic strategies for Holt-Oram syndrome.
Summary:
- Mutations in the T-box transcription factor TBX5 are identified as the cause of Holt-Oram syndrome.
- This syndrome is characterized by a familial predisposition to congenital heart disease and upper limb abnormalities.
- Recent research provides deeper insights into the genetic etiology and developmental origins of this condition.
Impact:
- Improved understanding of TBX5 mutations can lead to more accurate diagnoses of Holt-Oram syndrome.
- Advances in genetic insights may pave the way for novel therapeutic interventions.
- Enhanced knowledge of CHD genetics contributes to the broader field of developmental biology and personalized medicine.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Teratogenicity
Genetic Lingo

